Ureteral reflux study
CPT code 78740 represents a nuclear medicine imaging study that checks whether urine flows backward from the bladder into the ureters and kidneys, a condition called vesicoureteral reflux commonly seen in children with urinary tract infections.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Verify radiopharmaceutical (Tc-99m DTPA or sulfur colloid) administration is documented with dose, route, and time to support medical necessity
Impact: Missing radiopharmaceutical documentation results in 100% denial rate; proper documentation ensures full $202.81 reimbursement
Document both filling and voiding phases with number of images captured, as incomplete studies may only qualify for modifier 52 reduced payment
Impact: Incomplete study documentation can reduce reimbursement by 50% ($101.41) or result in complete denial
Bill global code without modifiers when practice owns equipment and physician interprets; split with 26/TC when services are divided
Impact: Incorrect modifier usage can delay payment by 30-45 days and may require resubmission with corrected claim
Separately report catheterization code (51701 or 51702) when performed as distinct service prior to reflux study
Impact: Adds $25-45 in additional reimbursement when appropriately documented as separate procedure
Ensure interpretation report specifies reflux grading (I-V), laterality, and clinical correlation with patient's UTI history
Impact: Detailed grading documentation reduces audit risk and supports medical necessity for repeat studies, protecting $202.81 payment
Verify prior authorization requirements for commercial payers, as many require pre-certification for nuclear medicine studies in pediatric patients
Impact: Lack of prior authorization results in denial rates exceeding 60% for commercial payers despite Medicare acceptance
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.